186 related articles for article (PubMed ID: 20096514)
1. Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject.
Marchei E; Farrè M; Pellegrini M; García-Algar O; Vall O; Pacifici R; Pichini S
Forensic Sci Int; 2010 Mar; 196(1-3):59-63. PubMed ID: 20096514
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of sweat testing for the detection of methylphenidate after fast- and extended-release drug administration: a pilot study.
Marchei E; Farré M; Pardo R; Garcia-Algar O; Pellegrini M; Pacifici R; Pichini S
Ther Drug Monit; 2010 Aug; 32(4):508-11. PubMed ID: 20535053
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatography-electrospray ionization mass spectrometry determination of methylphenidate and ritalinic acid in conventional and non-conventional biological matrices.
Marchei E; Farrè M; Pellegrini M; Rossi S; García-Algar O; Vall O; Pichini S
J Pharm Biomed Anal; 2009 Feb; 49(2):434-9. PubMed ID: 19117711
[TBL] [Abstract][Full Text] [Related]
4. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a liquid chromatography-mass spectrometry assay for hair analysis of methylphenidate.
Marchei E; Muñoz JA; García-Algar O; Pellegrini M; Vall O; Zuccaro P; Pichini S
Forensic Sci Int; 2008 Mar; 176(1):42-6. PubMed ID: 17980530
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
[TBL] [Abstract][Full Text] [Related]
7. The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspension.
Childress AC; Berry SA
Postgrad Med; 2010 Sep; 122(5):35-41. PubMed ID: 20861586
[TBL] [Abstract][Full Text] [Related]
8. A single-dose, two-way crossover, bioequivalence study of dexmethylphenidate HCl with and without food in healthy subjects.
Teo SK; Scheffler MR; Wu A; Stirling DI; Thomas SD; Stypinski D; Khetani VD
J Clin Pharmacol; 2004 Feb; 44(2):173-8. PubMed ID: 14747426
[TBL] [Abstract][Full Text] [Related]
9. Toxicokinetic assessment of methylphenidate (Ritalin) in a 13-week oral toxicity study in dogs.
Bakhtiar R; Ramos L; Tse FL
Biomed Chromatogr; 2004 Jan; 18(1):45-50. PubMed ID: 14872548
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of methylphenidate after oral administration of immediate and sustained-release preparations in Beagle dogs.
Lavy E; Prise U; Soldani G; Neri D; Brandriss N; Bar Chaim A; Giorgi M
Vet J; 2011 Sep; 189(3):336-40. PubMed ID: 20696604
[TBL] [Abstract][Full Text] [Related]
11. Correlation between methylphenidate and ritalinic acid concentrations in oral fluid and plasma.
Marchei E; Farré M; Pardo R; Garcia-Algar O; Pellegrini M; Pacifici R; Pichini S
Clin Chem; 2010 Apr; 56(4):585-92. PubMed ID: 20167695
[TBL] [Abstract][Full Text] [Related]
12. A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults.
Spencer TJ; Bonab AA; Dougherty DD; Martin J; McDonnell T; Fischman AJ
Int J Mol Med; 2010 Feb; 25(2):261-5. PubMed ID: 20043136
[TBL] [Abstract][Full Text] [Related]
13. Interindividual and Intraindividual Variation of Methylphenidate Concentrations in Serum and Saliva of Patients With Attention-Deficit/Hyperactivity Disorder.
Preiskorn J; Studer S; Rauh R; Lukačin R; Geffert C; Fleischhaker C; Clement HW; Schulz E; Biscaldi M
Ther Drug Monit; 2018 Aug; 40(4):435-442. PubMed ID: 29750737
[TBL] [Abstract][Full Text] [Related]
14. Analysis of methylphenidate and its metabolite ritalinic acid in monkey plasma by liquid chromatography/electrospray ionization mass spectrometry.
Doerge DR; Fogle CM; Paule MG; McCullagh M; Bajic S
Rapid Commun Mass Spectrom; 2000; 14(8):619-23. PubMed ID: 10786896
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers.
Arvidsson M; Dahl ML; Beck O; Ackehed G; Nordin K; Rosenborg S
Eur J Clin Pharmacol; 2020 Feb; 76(2):229-237. PubMed ID: 31786618
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of methylphenidate in man, rat and monkey.
Wargin W; Patrick K; Kilts C; Gualtieri CT; Ellington K; Mueller RA; Kraemer G; Breese GR
J Pharmacol Exp Ther; 1983 Aug; 226(2):382-6. PubMed ID: 6410043
[TBL] [Abstract][Full Text] [Related]
17. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
Marcus SC; Wan GJ; Kemner JE; Olfson M
Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
[TBL] [Abstract][Full Text] [Related]
18. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
[TBL] [Abstract][Full Text] [Related]
19. Disposition of gamma-hydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: issues in methodology and drug monitoring.
Abanades S; Farré M; Segura M; Pichini S; Pastor A; Pacifici R; Pellegrini M; de la Torre R
Ther Drug Monit; 2007 Feb; 29(1):64-70. PubMed ID: 17304152
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
